XML 100 R90.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidating Financial Statements (Cash Flow) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net cash provided by operating activities $ 288,937 $ 278,577
Cash flows from investing activities:    
Capital expenditures (49,463) (37,402)
Return of capital from investees 5,908 347
Investment in and loans to investees 0 (87,488)
Payments for acquisition of a business, net of cash acquired 0 (34,879)
Increase (decrease) to investment in affiliates 0 0
Net cash used in investing activities (43,555) (159,422)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units (23,019) (15,734)
Purchase of treasury stock (58,440) (242,409)
Proceeds from stock option exercises 4,630 4,317
Principal payments on finance lease obligations (2,590) (2,625)
Distributions to noncontrolling interests (10,129) (6,967)
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt (2,717) 0
Payments for financing costs   0
Net cash used in financing activities (92,265) (263,418)
Net increase (decrease) in cash and cash equivalents from operations 153,117 (144,263)
Effect of exchange rate changes on cash and cash equivalents (1,661) 1,604
Cash and cash equivalents at beginning of period 554,886 558,783
Cash and cash equivalents at end of period 706,342 416,124
Eliminations    
Cash flows from operating activities:    
Net cash provided by operating activities (394,915) (433,038)
Cash flows from investing activities:    
Capital expenditures 0 0
Return of capital from investees 0 0
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0 0
Increase (decrease) to investment in affiliates 265,383 701,129
Net cash used in investing activities 265,383 701,129
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0 0
Principal payments on finance lease obligations 0 0
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt 0 0
Payments for financing costs   0
Net cash used in financing activities 0 0
Net increase (decrease) in cash and cash equivalents from operations (129,532) 268,091
Effect of exchange rate changes on cash and cash equivalents 129,532 (268,091)
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Parent Company    
Cash flows from operating activities:    
Net cash provided by operating activities 273,682 296,928
Cash flows from investing activities:    
Capital expenditures 0 0
Return of capital from investees 0 0
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0 0
Increase (decrease) to investment in affiliates (221,104) (46,945)
Net cash used in investing activities (221,104) (46,945)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units (23,019) (15,734)
Purchase of treasury stock (58,440) (242,409)
Proceeds from stock option exercises 4,630 4,317
Principal payments on finance lease obligations 0 0
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt 0 0
Payments for financing costs   0
Net cash used in financing activities (76,829) (253,826)
Net increase (decrease) in cash and cash equivalents from operations (24,251) (3,843)
Effect of exchange rate changes on cash and cash equivalents 24,223 6,408
Cash and cash equivalents at beginning of period 121 320
Cash and cash equivalents at end of period 93 2,885
Guarantor Subsidiaries    
Cash flows from operating activities:    
Net cash provided by operating activities 400,444 852,314
Cash flows from investing activities:    
Capital expenditures (45,445) (32,827)
Return of capital from investees 0 0
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0 0
Increase (decrease) to investment in affiliates (44,279) (1,550,189)
Net cash used in investing activities (89,724) (1,583,016)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0 0
Principal payments on finance lease obligations (1,536) (1,464)
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt 0 0
Payments for financing costs   0
Net cash used in financing activities (1,536) (1,464)
Net increase (decrease) in cash and cash equivalents from operations 309,184 (732,166)
Effect of exchange rate changes on cash and cash equivalents (190,600) 584,331
Cash and cash equivalents at beginning of period 368,151 391,248
Cash and cash equivalents at end of period 486,735 243,413
Non- Guarantor Subsidiaries    
Cash flows from operating activities:    
Net cash provided by operating activities 9,726 (437,627)
Cash flows from investing activities:    
Capital expenditures (4,018) (4,575)
Return of capital from investees 5,908 347
Investment in and loans to investees 0 (87,488)
Payments for acquisition of a business, net of cash acquired 0 (34,879)
Increase (decrease) to investment in affiliates 0 896,005
Net cash used in investing activities 1,890 769,410
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0 0
Principal payments on finance lease obligations (1,054) (1,161)
Distributions to noncontrolling interests (10,129) (6,967)
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt (2,717) 0
Payments for financing costs   0
Net cash used in financing activities (13,900) (8,128)
Net increase (decrease) in cash and cash equivalents from operations (2,284) 323,655
Effect of exchange rate changes on cash and cash equivalents 35,184 (321,044)
Cash and cash equivalents at beginning of period 186,614 167,215
Cash and cash equivalents at end of period $ 219,514 $ 169,826